Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Rheumatic fever and rheumatic heart disease

Cardiology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Acute heart failure, severe carditis, haemodynamic valve disease, stroke or an unstable tachyarrhythmia needs same-day hospital care; chorea with unsafe behaviour or inability to eat/drink also requires urgent assessment.

Synopsis

Recognise post-streptococcal inflammatory disease, prevent recurrence and manage chronic valve damage in a UK pathway.

  • Acute rheumatic fever (ARF) is an immune-mediated complication usually appearing 1-5 weeks after group A streptococcal throat or skin infection.
  • Use revised Jones criteria plus evidence of preceding streptococcal infection; polyarthritis, carditis, chorea, erythema marginatum and subcutaneous nodules are the classic major manifestations.
  • Echocardiography with Doppler is required in suspected or confirmed ARF even when auscultation is normal because carditis may be subclinical.
  • Sydenham chorea and indolent carditis can present late, when streptococcal tests have normalised; do not reject the diagnosis solely for a negative ASO titre.
  • Eradicate residual streptococcus and start secondary prophylaxis after ARF; benzathine benzylpenicillin 1.2 million units IM every 3-4 weeks is the licensed adult regimen.
  • Prophylaxis duration is longer with carditis: at least 5 years/up to age 21 without cardiac involvement, at least 10 years/up to age 21 after transient carditis, and at least 10 years/up to age 40 with persistent involvement; some need lifelong prophylaxis.
  • Chronic rheumatic heart disease most often produces mitral stenosis/regurgitation, frequently with multivalve disease; assess AF, pulmonary pressure and pregnancy risk.
  • Antibiotic prophylaxis against infective endocarditis is not routinely offered for dental procedures solely because of rheumatic valve disease under NICE CG64.

Key red flags

Carditis

Tachycardia, new MR/AR murmur, cardiomegaly, pericarditic features or heart failure indicates pancardial involvement; Doppler-only valvulitis also counts.

High-risk decompensation

Pulmonary oedema, embolic neurology, pregnancy-related deterioration or fast AF with mitral stenosis needs urgent admission.

Investigation priorities

01
Throat culture/rapid GAS test and streptococcal serologyFirst step

Demonstrate preceding group A streptococcal infection.

Management branches

AcuteSuspected acute rheumatic fever

Compatible major/minor manifestations after possible GAS infection.

  1. Admit if carditis, heart failure, important arrhythmia, neurological risk or diagnostic instability; obtain ECG, inflammatory markers, GAS evidence and TTE.
  2. Apply revised Jones criteria and actively exclude septic arthritis, endocarditis, viral myocarditis, autoimmune disease and drug/toxin causes of chorea.
  3. Eradicate streptococcus even if the throat is now asymptomatic; treat arthritis/carditis and heart failure with paediatric/adult infection, cardiology and neurology input as appropriate.
  4. Before discharge, start secondary prophylaxis, document duration and create an echo/follow-up plan.

Key medicines

Benzathine benzylpenicillin1.2 million units by deep IM injection every 3-4 weeks for secondary prophylaxis; the SmPC also licenses 1.2 million units IM as a single general streptococcal treatment dose.Check immediate beta-lactam allergy; administer strictly IM with aspiration and emergency anaphylaxis capability. Long-term therapy needs periodic renal, hepatic and blood-count review.
Phenoxymethylpenicillin250 mg by mouth twice daily for prevention of recurrent rheumatic fever.Adherence is less reliable than depot injection; check penicillin allergy and renal function, and do not use an abbreviated course for active GAS eradication.
Open full textbook →Answer 2 questionsCardiology check
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NHS: Rheumatic feverCurrent UK recognition, timing and follow-up context.
  • Benzathine benzylpenicillin 1.2 million IU SmPCLicensed adult prophylaxis dose and duration by cardiac involvement.
  • Phenoxymethylpenicillin 250 mg tablets SmPCLicensed oral adult secondary-prophylaxis dose and renal/allergy cautions.
  • 2025 ESC/EACTS valvular heart disease guidelineChronic rheumatic valve intervention and anticoagulation context.
  • NICE CG64: Prophylaxis against infective endocarditisUK dental/endocarditis prophylaxis boundary.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom